Advertisement

European Journal of Nuclear Medicine

, Volume 14, Issue 7–8, pp 349–351 | Cite as

Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma

  • Klaus Buchali
  • Hans-Jacob Correns
  • Michael Schuerer
  • Dietmar Schnorr
  • Hildegard Lips
  • Karin Sydow
Article

Abstract

Forty-nine patients were treated with either 3×75 MBq 89Sr or saline as placebo. Analysis of results 1 to 3 years after therapy revealed the ineffectiveness of 89Sr to relieve pain from metastases. Unexpectedly, a higher survival rate was found after Sr application (46% vs 4% after 2 years). Covariate analysis underlines the effect of 89Sr therapy on life expectation.

Key words

Radionuclide therapy Skeletal metastases 89-strontium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blake GM, Zivanovic MA, McEwan AJ, Ackery DM (1986) Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med 12: 447–454Google Scholar
  2. Buchali K, Correns HJ, Schnorr D, Schuerer M, Sydow K, Lips H (1984) Therapie mit 89-Sr bei Knochenmetastasen von Prostatakarzinomen. In: Hoefer R (ed). Radioaktive Isotope in Klinik und Forschung 16. Egermann, Vienna, pp 151–157Google Scholar
  3. Correns HJ, Mebel M, Buchali K, Schnorr D, Seidel C, Mitterlechner E (1979) 89-Strontium therapy of bone metastases of carcinoma of the prostatic gland. Eur J Nucl Med 4: 33–34Google Scholar
  4. Correns HJ, Buchali K, Sydow K, Schuerer M, Schnorr D, Richter K (1982) Nuklearmedizinische Therapie von Metastasen des Skelettsystems. In: Schwartz D 19th Symposion Nuklearmedizin, Reinhardsbrunn, Schriftenreihe, Berlin pp 35–40Google Scholar
  5. Correns HJ, Buchali K, Schnorr D, Lips H, Sydow K, Schuerer M, Johannsen B (1986) On the efficacy of Strontium-89 therapy. Preliminary evaluation of a double-blind study. In: Winkler C (ed) Nuclear medicine in clinical oncology. Springer, Berlin Heidelberg New York Tokyo pp 345–347Google Scholar
  6. Cox DR (1972) Regression models and life tables. J R Statist Soc B 34: 187–220Google Scholar
  7. Firusian N, Mellin P, Schmidt CG (1976) Results of 89 Strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report. J Urology 116: 764Google Scholar
  8. Firusian N (1979) Radionuklidbehandlung von Skelettmetastasen. Nuklearmediziner 4: 314–327Google Scholar
  9. Kaul A, Oeff K, Roedler HD, Vogelsang T (1973) Die Strahlenbelastung von Patienten bei der nuklearmedizinischen Anwendung offener radioaktiver Stoffe. Informationsdienst Nuclearmedizin BerlinGoogle Scholar
  10. Kutzner J, Grimm W, Hahn K (1977) Interne Strahlentherapie mit Strontium 89 bei metastasenbedingten Schmerzzustaenden. Muench Med Wochenschr 119: 1251Google Scholar
  11. Kutzner J, Grimm W, Brod KH, Roesler A (1982) Die Yttrium-90 Therapie von Knochenmetastasen. Dtsch Med Wochenschr 107: 1360–1361Google Scholar
  12. Langhammer H, Sintermann R, Hoer G, Pabst HW (1978) Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer. J Nucl Med 17: 87–91Google Scholar
  13. Levenson RM, Sauerbrunn BJL, Bates HR, Newman RD, Eddy JL, Ihde DC (1983) Comparative value of bone scintigraphy and radiography in monitoring tumor response in systematically treated prostatic carcinoma. Radiology 146: 513–518Google Scholar
  14. Schmid L, Langhammer H, Braun J, Oberdorfer M, Steuer G, Herz R, Pabst HW (1982) Skelettszintigraphische und radiologische Befunde bei 403 Prostatakarzinompatienten in Primaerdiagnostik, Verlaufs- und Therapiekontrolle. In: Hoefer R (ed) Radioaktive Isotope in Klinik und Forschung 15. Egermann, Vienna pp 349–360Google Scholar
  15. Silberstein EB, Williams C (1985) Strontium-89 therapy for the pain of osseous metastases. J Nucl Med 26: 345–348Google Scholar
  16. Snyder WS, Ford MR, Warner GG, Watson SB (1975) MIRD pamphlet No. 11. Soc Nucl MedGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Klaus Buchali
    • 1
    • 2
  • Hans-Jacob Correns
    • 1
    • 2
  • Michael Schuerer
    • 1
    • 2
  • Dietmar Schnorr
    • 1
    • 2
  • Hildegard Lips
    • 1
    • 2
  • Karin Sydow
    • 1
    • 2
  1. 1.Klinik für Nuklearmedizin, Bereich Medizin (Charitè)Humboldt-UniversitätBerlinGerman Democratic Republic
  2. 2.Klinik für Urologie, Bereich Medizin (Charitè)Humboldt-UniversitätBerlinGerman Democratic Republic

Personalised recommendations